Table 1.
Selected differentially expressed genes and results of validation with qRT-PCR
| Gene | Up-/Down- regulation in T versus B | Probe – poly(A)-tail distance (nt) | Relative expression levels (AU) | |
| T | B | |||
| lost in two rounds (figure 5C): | ||||
| SLC1A6 | Up | 803 | 106 | 1 |
| PTHLH | Up | 1,096 | 69 | 1 |
| DKK3 | Up | 1,104 | 14 | 1 |
| CGN | Down | 693 | 1 | 363 |
| IL18 | Down | 715 | 1 | 7 |
| PTGFR | Down | 835 | 1 | 40 |
| CCND1 | Down | 965 | 1 | 21 |
| DAF | Down | 1,016 | 1 | 3 |
| KRT7 | Down | 1,026 | 1 | 35 |
| NCOA7 | Down | 2,106 | 1 | 0.7 |
| persistent in two rounds (figure 5C): | ||||
| SOST | Up | 891 | 741 | 1 |
| MCM6 | Up | 1,039 | 29 | 1 |
| SDC2 | Up | 2,530 | 108 | 1 |
| CAPS | Down | 573 | 1 | 19 |
| B2M | Down | 648 | 1 | 1.6 |
| NME5 | Down | 704 | 1 | 798 |
| DCN | Down | 816 | 1 | 19 |
| NS3TP2 | Down | 820 | 1 | 24 |
| GSTA1 | Down | 824 | 1 | 14 |
| UBXD3 | Down | 1,738 | 1 | 72 |
T, tumor; B, bronchus; nt, nucleotides; AU, arbitrary units.